Caption Management, LLC Tg Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $516,300 - $758,400	30,000 New	30,000 $701,000
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $3.43 Million - $5.61 Million	-263,600 Reduced 91.91%	23,200 $352,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $733,464 - $2.07 Million	109,800 Added 62.03%	286,800 $4.9 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $2.53 Million - $8.03 Million	-302,900 Reduced 63.12%	177,000 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $4.24 Million - $9.58 Million	273,800 Added 132.85%	479,900 $11.9 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $11.8 Million - $22.2 Million	-1,149,900 Reduced 84.8%	206,100 $3.1 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $6.08 Million - $14.4 Million	1,214,300 Added 856.95%	1,356,000 $16 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $2.13 Million - $3.91 Million	-465,000 Reduced 76.64%	141,700 $838,000
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $1.59 Million - $4.53 Million	425,100 Added 234.09%	606,700 $2.58 Million
Q1 2022 May 13, 2022	BUY	$7.81 - $20.45 $1.07 Million - $2.79 Million	136,600 Added 303.56%	181,600 $1.73 Million
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $1.2 Million - $2.22 Million	-55,000 Reduced 55.0%	45,000 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $8.8 Million - $13.3 Million	-270,900 Reduced 73.04%	100,000 $3.88 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $494,088 - $1.11 Million	69,200 Added 22.94%	370,900 $3.65 Million
Q4 2019 Feb 13, 2020	BUY	$5.1 - $11.2 $1.54 Million - $3.38 Million	301,700 New	301,700 $3.35 Million
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $801,620 - $1.34 Million	-149,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $934,229 - $1.29 Million	149,000 New	149,000 $1.29 Million
Q4 2018 Jan 30, 2019	SELL	$3.44 - $5.76 $601,656 - $1.01 Million	-174,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $900,735 - $2.45 Million	174,900 New	174,900 $979,000

Others Institutions Holding TGTX

# of Institutions

349

Shares Held

89.5M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$488 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$361 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$288 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$114 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$102 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.61B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account